A heparin binding synthetic peptide from human HIP/RPL29 fails to specifically differentiate between anticoagulantly active and inactive species of heparin

Journal of Negative Results in BioMedicine

Volumn 2, Issue , 2003, Pages 1-10

  Hoke, David E ^a,b   Carson, Daniel D ^c   Höök, Magnus ^a  

^a TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c UNIVERSITY OF DELAWARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; HEPARIN BINDING PROTEIN; HEPARIN FRACTION; HIP PEPTIDE 1; PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ANION EXCHANGE CHROMATOGRAPHY; ANTICOAGULATION; ARTICLE; BINDING AFFINITY; HUMAN; ION EXCHANGE CHROMATOGRAPHY; PROTEIN INTERACTION;

ANIMALS; ANTICOAGULANTS; ANTITHROMBIN III; BINDING SITES; BLOOD COAGULATION FACTORS; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, ION EXCHANGE; GLYCOSAMINOGLYCANS; HEPARIN; HUMANS; INTESTINAL MUCOSA; PEPTIDE FRAGMENTS; SWINE;

EID: 3042549830     PISSN: 14775751     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-5751-2-1     Document Type: Article

References (20)

1. Salmivirta M, Lidholt K and Lindahl U Heparan sulfate: a piece of information. FASEB J 1996, 10:1270-9
2. Hook M, Bjork I, Hopwood JJ and Lindahl U Anticoagulant activity of heparin: separation of high activity and low activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett 1976, 66:90-93
3. Lam LH, Silbert JE and Rosenberg RD The separation of active and inactive forms of heparin. Biochem Biophys Res Commun 1976, 69:570-577
4. Lindahl U, Backstrom G, Hook M, Thunberg L, Fransson L-A and Linker A Structure of the antithrombin-binding site in heparin. Proc Natl Acad Sci USA 1979, 76:3198-3202
5. Lindahl U, Backstrom G, Thunberg L and Leder IG Evidence of a 3-O-sulfated D-glucosamine residue in the antithrombin-binding sequence of heparin. Proc Natl Acad Sci USA 1980, 77:6551-6555
6. McKeehan WL, Wu X and Kan M Requirement for anticoagulant heparan sulfate in the fibroblast growth factor receptor complex. J Biol Chem 1999, 274:21511-4
7. Liu S, Zhou F, Hook M and Carson DD A heparin-binding synthetic peptide of heparin/heparan sulfate-interacting protein modulates blood coagulation activities. Proc Natl Acad Sci U S A 1997, 94:1739-44
8. Loo BM, Kreuger J, Jalkanen M, Lindahl U and Salmivirta M Binding of heparin/heparan sulfate to fibroblast growth factor receptor. J Biol Chem 2001, 276:16868-76
9. Conrad HE Heparin binding proteins New York-London Academic Press 1998,
10. Zhang L, Beeler DL, Lawrence R, Lech M, Liu J, Davis JC, Shriver Z, Sasisekharan R and Rosenberg RD 6-O-Sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway. J Biol Chem 2001, 276:42311-21
11. Hurst RE, Menter JM, West SS, Settine JM and Coyne EH Structural basis for the anticoagulant activity of heparin. Relationship to the number of charged groups. Biochemistry 1979, 18:4283-7
12. Hurst RE, Poon MC and Griffith MJ Structure-activity relationships of heparin. Independence of heparin charge density and antithrombin-binding domains in thrombin inhibition by antithrombin and heparin cofactor II. J Clin Invest 1983, 72:1042-5
13. Liu S, Julian J and Carson DD A peptide sequence of heparin/heparan sulfate (HP/HS)-interacting protein supports selective, high affinity binding of HP/HS and cell attachment. J Biol Chem 1998, 273:9718-26
14. Cardin AD and Weintraub HJ Molecular modeling of protein-glycosaminoglycan interactions. Arteriosclerosis 1989, 9:21-32
15. Verrecchio A, Germann MW, Schick BP, Kung B, Twardowski T and San Antonio JD Design of peptides with high affinities for heparin and endothelial cell proteoglycans. J Biol Chem 2000, 17:7701-7
16. Schick BP, Gradowski JF, San Antonio JD and Martinez J Novel design of peptides to reverse the anticoagulant activities of heparin and other glycosaminoglycans. Thromb Haemost 2001, 85:482-7
17. Hoke DE, LaBrenz SR, Hook M and Carson DD Multiple domains contribute to heparin/heparan sulfate binding by human HIP/L29. Biochemistry 2000, 39:15686-94
18. Farndale RW, Sayers CA and Barrett AJ A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982, 9:247-248
19. Forsberg E, Pejler G, Ringvall M, Lunderius C, Tomasini-Johansson B, Kusche-Gullberg M, Eriksson I, Ledin J, Hellman L and Kjellen L Abnormal mast cells in mice deficient in a heparin-synthesizing enzyme. Nature 1999, 19:773-6
20. Wickerhauser M and Williams C A single-step method for the isolation of antithrombin III. Vox Sang 1984, 47:397-405